Search
Search Results
-
Successful Treatment of Schwartz-Jampel Syndrome with Botulinum Toxin Type A
Schwartz-Jampel syndrome (SJS) is a rare autosomal recessive disorder characterized by typical facial dysmorphism, generalized muscle stiffness,...
-
A Phase III Clinical Study of the Efficacy and Safety of Botulinum Toxin Type A (MASPORT) with DYSPORT for the Treatment of Glabellar Lines
BackgroundBotulinum toxin type A is a widely used treatment of facial wrinkles. The objective of this study was to compare the efficacy and safety of...
-
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up
Botulinum toxin A (BoNT/A) is the first-line treatment for idiopathic cervical dystonia (ICD) and is widely used in the clinical setting. To date,...
-
Botulinum Toxin for Neurogenic and Non-neurogenic Bladder Pain
Purpose of ReviewThe use of botulinum toxin in managing urinary incontinence has been well established. Given the expanding indications for this...
-
Efficacy and Safety of Botulinum Toxin Type A for Treatment of Glabellar Lines: A Network Meta-Analysis of Randomized Controlled Trials
BackgroundBotulinum toxin type A (BoNT/A) has been used in aesthetic applications worldwide, including glabellar lines. Currently, four BoNT/A...
-
The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystonia
BackgroundRepeated injections with abo- or onabotulinumtoxin type A (aboBoNT/A, onaBoNT/A) may lead to induction of neutralizing antibodies (NABs)...
-
Temporalis Muscle Changes Following Botulinum Toxin A Injections in Masseter Hypertrophy Patients: A Randomized Triple-Blinded Trial
BackgroundThis study aimed to elucidate the effects of botulinum toxin A (BoNT-A) treatment for patients diagnosed with masseter hypertrophy on the...
-
-
Significantly lower antigenicity of incobotulinumtoxin than abo- or onabotulinumtoxin
BackgroundFor many indications, BoNT/A is repetitively injected with the risk of develo** neutralizing antibodies (NABs). Therefore, it is...
-
Alternative Clinical Indications of Botulinum Toxin
Botulinum toxin type A (BoNTA) is a powerful neurotoxin that inhibits acetylcholine release from presynaptic vesicles. The potency and safety profile...
-
Botulinum toxin therapy of dystonia
Botulinum toxin (BT) is used to treat a large number of muscle hyperactivity syndromes. Its use in dystonia, however, is still one of the most...
-
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity
Botulinum toxin (BT) therapy is a complex and highly individualised therapy defined by treatment algorithms and injection schemes describing its...
-
Botulinum Toxin Versus Placebo: A Meta-Analysis of Treatment and Quality-of-life Outcomes for Hyperhidrosis
AimsThis study aims at assessing the treatment effect, disease severity and quality-of-life outcomes of botulinum toxin (BTX) injections for focal...
-
A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis
Microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis radiofrequency (RF) technology is a new modality that applied...
-
The impact of the initial severity on later outcome: retrospective analysis of a large cohort of botulinum toxin naïve patients with idiopathic cervical dystonia
BackgroundThe aim of study was to demonstrate that the first three injections of botulinum neurotoxin type A (BoNT/A) appear to be less effective in...
-
A Phase 3, Randomized, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Neu-BoNT/A in Treatment of Primary Axillary Hyperhidrosis
BackgroundBotulinum toxin type A is widely used to treat primary axillary hyperhidrosis and has proven to be an effective and safe approach....
-
Multimodal treatment, including extracorporeal shock wave therapy, for refractory chronic tension-type headache: a case report
BackgroundFew reports have described multidisciplinary treatment, including extracorporeal shock wave therapy, for patients with refractory chronic...
-
Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study
Apart from the known efficacy of Botulinum Neurotoxin Type A (BoNT/A) in hyperactive striated and smooth muscles, different pain states have become...
-
Effects of different doses of abobotulinumtoxinA for the treatment of anterior gingival smile
Botulinum toxin type A (BoNT-A) is an easy and fast treatment for gingival smile (GS). The objective of the study was to compare the reduction of...
-
Neue Botulinumtoxine in der ästhetischen Dermatologie
Facial rejuvenation is gaining immense popularity among patients and clinicians. Botulinum toxins derived from bacteria are well-tolerated options as...